HAEMONETICS CORP : Change in Directors or Principal Officers (form 8-K)

HAE

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b)

Dan Goldstein, Vice President, Corporate Controller and Principal Accounting Officer will leave Haemonetics Corporation (the "Company") on August 9, 2022. The Company is grateful for Mr. Goldstein's meaningful contributions during his time at the Company. Mr. Goldstein will remain in his current role while the Company conducts a search for his successor.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses